Immunic is trading 5.74% up now at $11.23, alongside a broadly stronger pre-market session.

  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each up more than 0.5%.
  • Falling oil prices and improved global risk appetite are supporting equities.
  • No fresh company-specific announcement was identified for September 21, 2026; latest developments remain its September 9 multiple-sclerosis R&D Day and earlier leadership updates.